Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The investigators identified 64,000+ adults aged 45 or older with overweight or obesity and atherosclerotic cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) but no diabetes diagnosis, who initiated semaglutide or tirzepatide between May 2022 and January 2025
JAMA Neurol
While evidence suggests central mediation, possibly through dopamine signaling, the precise neurocircuit-level mechanisms are yet to be fully elucidated
Kieffer 2 Endocrinology and Metabolism 2013;28(4):262-274
Increase dose : If 4 weeks at same dose with no loss, increase to next level
Tirzepatide is a 39-amino-acid peptide with a C20 fatty diacid moiety attached, making it one of the most complex GLP-1 receptor agonists ever developed
US$ 27.91
US$ 22.55
US$ 26.00
